- Disease: Acute SARS-CoV-2
- Study type: Observational Cohort Study, Treatment
- Study type descriptors: Retrospective, Single centre
- Objective: To evaluate the effectiveness and tolerability of three antiviral drugs - molnupiravir, remdesivir, and nirmatrelvir/ritonavir - in treating mild-to-moderate COVID-19 in high-risk patients in a real-life setting
- Number of participants enrolled: 1118
- Study enrolling from to
- Study includes follow-up for 1 month
Study Data
- Adults
- Elderly
- Fragile population
- Outpatient clinic
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Nirmatrelvir/Ritonavir
- Remdesivir
- Molnupiravir
External Links
Other information
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to